Development of Domain‐Selective Angiotensin I‐Converting Enzyme Inhibitors
- 1 November 2005
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1056 (1), 160-175
- https://doi.org/10.1196/annals.1352.035
Abstract
Somatic angiotensin-converting enzyme (ACE) is an essential component of the renin-angiotensin system and consequently plays a key role in blood pressure and electrolyte homeostasis. Thus, ACE inhibitors are widely used in the treatment of cardiovascular disease, causing a decrease in the production of angiotensin II and an increase in the circulating vasodilator bradykinin. The ectodomain of ACE consists of two parts (N and C domains), each bearing an active site that differs in substrate and inhibitor specificity. Advances in the elucidation of the functional roles of these two domains and an expanded view of the renin-angiotensin system underscore the need for the next generation of domain-selective inhibitors with improved pharmacologic profiles. Moreover, recent breakthroughs in determining the crystal structure of testis ACE (identical to the C domain) and its homologue ACE2 provide new mechanistic insights into the interactions of ACE inhibitors and substrates with active site pockets. This review summarizes the structural basis and recent synthetic chemistry approaches to the development of novel domain-selective inhibitors.Keywords
This publication has 66 references indexed in Scilit:
- Domain‐Selective Ligand‐Binding Modes and Atomic Level Pharmacophore Refinement in Angiotensin I Converting Enzyme (ACE) InhibitorsChemBioChem, 2005
- Phosphinic peptides as zinc metalloproteinase inhibitorsCellular and Molecular Life Sciences, 2004
- Peptidyl-dipeptidase A/angiotensin I-converting enzymePublished by Elsevier BV ,2004
- ACE inhibition actively promotes cell survival by altering gene expressionBiochemical and Biophysical Research Communications, 2003
- Small, noncovalent serine protease inhibitorsMedicinal Research Reviews, 1999
- [18] Peptidyl dipeptidase A: Angiotensin I-converting enzymeMethods in enzymology, 1995
- N-Glycosylation of Forms of Angiotensin Converting Enzyme from Four Mammalian SpeciesBiochemical and Biophysical Research Communications, 1993
- Purification and characterization of recombinant human testis angiotensin-converting enzyme expressed in chinese hamster ovary cellsProtein Expression and Purification, 1991
- The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting EnzymePublished by Wiley ,1985
- Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) fromBothrops jararaca venomCellular and Molecular Life Sciences, 1965